Transdermal therapeutic system for treating Parkinsonism
US7413747B2 · kind B2 · utility
22Cited by
1References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 31, 2007 |
| Grant date | Aug 19, 2008 |
| Priority date | — |
| Expiry date | Oct 31, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A transdermal therapeutic system (TTS) comprises a silicone-based polymer adhesive system having distributed therein (−)-5,6,7,8-tetrahydro-6-[propyl-[2-(2-thienyl)ethyl]amino]-1-naphthalenol free base in an amount of about 5% to 40% by weight. The adhesive system comprises a silicone adhesive and an additive having increased solubility for the active substance, in an amount effective to increase dissolving capacity of the matrix for the active substance.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.